Brief: AN2 Therapeutics Posts Quarterly Loss Per Share $2.98

AN2 Therapeutics

10/05/2022 23:01

May 10 (Reuters) - AN2 Therapeutics Inc  ANTX.O :
    * AN2 THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
    * EXPECTS  CURRENT CASH, CASH EQUIVALENTS AND INVESTMENTS,
WILL BE
SUFFICIENT TO FUND ITS OPERATING EXPENSES THROUGH MID-2024
    * QTRLY LOSS PER SHARE $2.98
    * Q1 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX1fJfkx 
Further company coverage:  ANTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))